EPISODE · Mar 27, 2023 · 34 MIN
Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines
from Keeping Current CME
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer? Credit available for this activity expires: 3/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990129?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines
0:00
34:58
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 34 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 27, 2023.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!